Glyceryl Trinitrate Bristol Laboratories (Glyceryl Trinitrate)

Glyceryl Trinitrate Bristol Laboratories is primarily prescribed for conditions where the heart requires reduced oxygen demand.

• Acute relief of angina pectoris episodes.
• Prevention of angina attacks during physical exertion or emotional stress.
• Management of acute myocardial ischemia in emergency settings.
• Adjunct therapy in diagnostic procedures that may provoke coronary spasm.
• Short‑acting sublingual treatment to rapidly lower cardiac preload.
• Use in combination with long‑acting nitrate regimens for chronic angina control.

The safety profile of Glyceryl Trinitrate Bristol Laboratories reflects the typical effects observed with sublingual organic nitrates.

Common

• Headache, often described as throbbing, due to vasodilation.
• Flushing or warmth in the face and neck.
• Dizziness or light‑headedness, especially when standing quickly.
• Nausea or mild gastrointestinal discomfort.
• Sweating (diaphoresis) during an episode.
• Feeling of palpitations or rapid heartbeat.
• Dry mouth or metallic taste.

Serious

• Severe hypotension leading to fainting or shock.
• Rapid or irregular heart rhythm (arrhythmia).
• Methemoglobinemia, a rare blood disorder affecting oxygen transport.
• Chest pain that does not improve with repeat dosing (possible nitrate tolerance).
• Allergic reaction such as rash, itching, or swelling.
• Severe headache unresponsive to over‑the‑counter analgesics.

When prescribing Glyceryl Trinitrate Bristol Laboratories, clinicians consider several precautionary factors to minimize risk and ensure appropriate use.

• Assess blood pressure before administration; avoid use in patients with severe hypotension.
• Review patient history for recent use of phosphodiesterase‑5 inhibitors, as combined effect may cause dangerous blood pressure drops.
• Evaluate for known hypersensitivity to organic nitrates or any component of the formulation.
• Consider dose adjustment in patients with hepatic impairment, given altered metabolism.
• Counsel patients on proper sublingual technique to prevent swallowing and reduced efficacy.
• Monitor for signs of tolerance with long‑term therapy and rotate dosing intervals as recommended.

Glyceryl Trinitrate Bristol Laboratories can interact with other medicines, affecting blood pressure or nitrate metabolism.

Avoid

• Concomitant use with phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) – may cause profound hypotension.
• Simultaneous administration of other potent vasodilators (e.g., hydralazine, nitroprusside) – risk of additive blood pressure lowering.
• Use with alcohol in excess – can enhance dizziness and hypotensive effects.

Use with caution

• Beta‑blockers or calcium‑channel blockers – monitor cardiovascular response.
• Antihypertensive agents such as ACE inhibitors or ARBs – adjust dosing as needed.
• General anesthetics containing volatile agents – may potentiate vasodilatory response.